Forecast & Rating5 analysts currently cover Lakefront Biotherapeutics, with about 0.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $25.30, about 9.1% downside from the current price of $27.84. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most institutions are cautious on Lakefront Biotherapeutics's outlook. Data as of Jul 11, 2026; for reference only and not investment advice.
Jul 10, 2026
Price forecast
$25.30-9.13%
Forecast & RatingHold
5analysts
Strong buy0.00%
Buy0.00%
Hold80.00%
Sell20.00%
Strong sell0.00%
Strong buy
0
Buy
0
Hold
4
Sell
1
Strong sell
0
Target price forecast
Forecast baselineJul 23, 2026
Forecast met11.3%
Stock price$27.84
Average forecast price$25.3
Highest forecast price$30
Lowest forecast price$19
Average forecast price
$25.3
Highest forecast price
$30
Lowest forecast price
$19
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.